These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Breast carcinoma with lung and bone metastases treated with laetrile; case report. NAVARRO MD; LAGMAN CL J Philipp Med Assoc; 1957 Jan; 33(1):16-20. PubMed ID: 13417107 [No Abstract] [Full Text] [Related]
4. [Use of Bayer E 39 in otolaryngology; clinical and histological study]. BAUER E Krebsarzt; 1957 Jun; 12(3):129-50. PubMed ID: 13450291 [No Abstract] [Full Text] [Related]
5. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms]. DI PIETRO S Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502 [No Abstract] [Full Text] [Related]
7. [Preliminary report on the use of a new cytotoxic drug in the treatment of tumors]. ROSA L; GIUNGI F; FRANCO T Riforma Med; 1957 Jun; 71(22):619-20. PubMed ID: 13454504 [No Abstract] [Full Text] [Related]
8. [New antineoplastic drugs]. DE SOCIO V Rass Int Clin Ter; 1957 Feb; 37(4):148-54. PubMed ID: 13420462 [No Abstract] [Full Text] [Related]
9. [Preliminary study on the use of the cytostatic drug E 39 in the therapy of prostate carcinoma]. CHIEREGO F; FABRIS P Riforma Med; 1957 Jun; 71(22):615-8. PubMed ID: 13454503 [No Abstract] [Full Text] [Related]
10. [First results concerning the effects of the cytostatic drug Bayer E-39]. VERGA P; PERRONE V Riforma Med; 1957 Jun; 71(22):604-7. PubMed ID: 13454501 [No Abstract] [Full Text] [Related]
11. [Paradoxical effects of E 39]. DUCHESNAY G Bull Med; 1957 Jan; 71(1):22. PubMed ID: 13413431 [No Abstract] [Full Text] [Related]
12. Response of breast cancer to triethylene thiophosphoramide; pathological and clinical findings. MOORE GE; PICKREN JW AMA Arch Pathol; 1958 Jan; 65(1):98-103. PubMed ID: 13487035 [No Abstract] [Full Text] [Related]
13. [Clinical observations on the use of the compound E 39 in anticellular chemotherapy]. CONSOLI G; RUSSO N Riforma Med; 1957 Jun; 71(22):624-9. PubMed ID: 13454506 [No Abstract] [Full Text] [Related]
14. [Failure of attempted treatment of multiregional lymphosarcomatosis with the new antitumoral quinone E 39]. MOULINIER J J Med Bord; 1957 Jul; 134(7):953-6. PubMed ID: 13449493 [No Abstract] [Full Text] [Related]
15. [Fundamentals & problems of chemotherapy of tumors]. DOMAGK G Riforma Med; 1957 Jun; 71(22):601-3. PubMed ID: 13454500 [No Abstract] [Full Text] [Related]
16. [E 39, a new antitumoral substance of the ethyleneimine-qulnone group; properties and clinical indications]. PESTEL M Presse Med (1893); 1956 Sep; 64(64):1474-5. PubMed ID: 13379258 [No Abstract] [Full Text] [Related]
17. [Comparison of endocrine therapy and chemotherapy for bone metastasis of breast cancer]. Yan M; Song ST; Jiang ZF; Zhang SH; Liu XQ; Xu JM; Wang T; Luo WD Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):177-80. PubMed ID: 15196443 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of plasmocytoma with a ethyleneiminoquinone derivative (Bayer E 39 cytostatic)]. DOENECKE F; HERMANN G Medizinische; 1957 May; (18):686-9. PubMed ID: 13440425 [No Abstract] [Full Text] [Related]
20. [Notes on the use of a new cytostatic drug in chemotherapy of tumors]. MELAMPI M Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1619-22. PubMed ID: 13446158 [No Abstract] [Full Text] [Related] [Next] [New Search]